Table of Contents
2019-2024 Global Intravenous Immune Globulin Therapies Market Report (Status and Outlook)
1 Scope of the Report
1.1 Market Introduction
1.2 Research Objectives
1.3 Years Considered
1.4 Market Research Methodology
1.5 Economic Indicators
1.6 Currency Considered
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Intravenous Immune Globulin Therapies Market Size 2014-2024
2.1.2 Intravenous Immune Globulin Therapies Market Size CAGR by Region
2.2 Intravenous Immune Globulin Therapies Segment by Type
2.2.1 Liquid Form
2.2.2 Lyophilized Powder Form
2.3 Intravenous Immune Globulin Therapies Market Size by Type
2.3.1 Global Intravenous Immune Globulin Therapies Market Size Market Share by Type (2014-2019)
2.3.2 Global Intravenous Immune Globulin Therapies Market Size Growth Rate by Type (2014-2019)
2.4 Intravenous Immune Globulin Therapies Segment by Application
2.4.1 Immunodeficiency
2.4.2 Autoimmune Disease
2.4.3 Acute Infection
2.5 Intravenous Immune Globulin Therapies Market Size by Application
2.5.1 Global Intravenous Immune Globulin Therapies Market Size Market Share by Application (2014-2019)
2.5.2 Global Intravenous Immune Globulin Therapies Market Size Growth Rate by Application (2014-2019)
3 Global Intravenous Immune Globulin Therapies by Players
3.1 Global Intravenous Immune Globulin Therapies Market Size Market Share by Players
3.1.1 Global Intravenous Immune Globulin Therapies Market Size by Players (2017-2019)
3.1.2 Global Intravenous Immune Globulin Therapies Market Size Market Share by Players (2017-2019)
3.2 Global Intravenous Immune Globulin Therapies Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) (2017-2019)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 Intravenous Immune Globulin Therapies by Regions
4.1 Intravenous Immune Globulin Therapies Market Size by Regions
4.2 Americas Intravenous Immune Globulin Therapies Market Size Growth
4.3 APAC Intravenous Immune Globulin Therapies Market Size Growth
4.4 Europe Intravenous Immune Globulin Therapies Market Size Growth
4.5 Middle East & Africa Intravenous Immune Globulin Therapies Market Size Growth
5 Americas
5.1 Americas Intravenous Immune Globulin Therapies Market Size by Countries
5.2 Americas Intravenous Immune Globulin Therapies Market Size by Type
5.3 Americas Intravenous Immune Globulin Therapies Market Size by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Key Economic Indicators of Few Americas Countries
6 APAC
6.1 APAC Intravenous Immune Globulin Therapies Market Size by Countries
6.2 APAC Intravenous Immune Globulin Therapies Market Size by Type
6.3 APAC Intravenous Immune Globulin Therapies Market Size by Application
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 Key Economic Indicators of Few APAC Countries
7 Europe
7.1 Europe Intravenous Immune Globulin Therapies by Countries
7.2 Europe Intravenous Immune Globulin Therapies Market Size by Type
7.3 Europe Intravenous Immune Globulin Therapies Market Size by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
7.9 Spain
7.10 Key Economic Indicators of Few Europe Countries
8 Middle East & Africa
8.1 Middle East & Africa Intravenous Immune Globulin Therapies by Countries
8.2 Middle East & Africa Intravenous Immune Globulin Therapies Market Size by Type
8.3 Middle East & Africa Intravenous Immune Globulin Therapies Market Size by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers and Impact
9.1.1 Growing Demand from Key Regions
9.1.2 Growing Demand from Key Applications and Potential Industries
9.2 Market Challenges and Impact
9.3 Market Trends
10 Global Intravenous Immune Globulin Therapies Market Forecast
10.1 Global Intravenous Immune Globulin Therapies Market Size Forecast (2019-2024)
10.2 Global Intravenous Immune Globulin Therapies Forecast by Regions
10.2.1 Global Intravenous Immune Globulin Therapies Forecast by Regions (2019-2024)
10.2.2 Americas Market Forecast
10.2.3 APAC Market Forecast
10.2.4 Europe Market Forecast
10.2.5 Middle East & Africa Market Forecast
10.3 Americas Forecast by Countries
10.3.1 United States Market Forecast
10.3.2 Canada Market Forecast
10.3.3 Mexico Market Forecast
10.3.4 Brazil Market Forecast
10.4 APAC Forecast by Countries
10.4.1 China Market Forecast
10.4.2 Japan Market Forecast
10.4.3 Korea Market Forecast
10.4.4 Southeast Asia Market Forecast
10.4.5 India Market Forecast
10.4.6 Australia Market Forecast
10.5 Europe Forecast by Countries
10.5.1 Germany Market Forecast
10.5.2 France Market Forecast
10.5.3 UK Market Forecast
10.5.4 Italy Market Forecast
10.5.5 Russia Market Forecast
10.5.6 Spain Market Forecast
10.6 Middle East & Africa Forecast by Countries
10.6.1 Egypt Market Forecast
10.6.2 South Africa Market Forecast
10.6.3 Israel Market Forecast
10.6.4 Turkey Market Forecast
10.6.5 GCC Countries Market Forecast
10.7 Global Intravenous Immune Globulin Therapies Forecast by Type
10.8 Global Intravenous Immune Globulin Therapies Forecast by Application
11 Key Players Analysis
11.1 Baxter
11.1.1 Company Details
11.1.2 Intravenous Immune Globulin Therapies Product Offered
11.1.3 Baxter Intravenous Immune Globulin Therapies Revenue, Gross Margin and Market Share (2017-2019)
11.1.4 Main Business Overview
11.1.5 Baxter News
11.2 Grifols
11.2.1 Company Details
11.2.2 Intravenous Immune Globulin Therapies Product Offered
11.2.3 Grifols Intravenous Immune Globulin Therapies Revenue, Gross Margin and Market Share (2017-2019)
11.2.4 Main Business Overview
11.2.5 Grifols News
11.3 CSL Plasma
11.3.1 Company Details
11.3.2 Intravenous Immune Globulin Therapies Product Offered
11.3.3 CSL Plasma Intravenous Immune Globulin Therapies Revenue, Gross Margin and Market Share (2017-2019)
11.3.4 Main Business Overview
11.3.5 CSL Plasma News
11.4 Octapharma
11.4.1 Company Details
11.4.2 Intravenous Immune Globulin Therapies Product Offered
11.4.3 Octapharma Intravenous Immune Globulin Therapies Revenue, Gross Margin and Market Share (2017-2019)
11.4.4 Main Business Overview
11.4.5 Octapharma News
11.5 Biotest
11.5.1 Company Details
11.5.2 Intravenous Immune Globulin Therapies Product Offered
11.5.3 Biotest Intravenous Immune Globulin Therapies Revenue, Gross Margin and Market Share (2017-2019)
11.5.4 Main Business Overview
11.5.5 Biotest News
11.6 Kedrion
11.6.1 Company Details
11.6.2 Intravenous Immune Globulin Therapies Product Offered
11.6.3 Kedrion Intravenous Immune Globulin Therapies Revenue, Gross Margin and Market Share (2017-2019)
11.6.4 Main Business Overview
11.6.5 Kedrion News
11.7 Kamada
11.7.1 Company Details
11.7.2 Intravenous Immune Globulin Therapies Product Offered
11.7.3 Kamada Intravenous Immune Globulin Therapies Revenue, Gross Margin and Market Share (2017-2019)
11.7.4 Main Business Overview
11.7.5 Kamada News
11.8 China Biologic Products Holdings
11.8.1 Company Details
11.8.2 Intravenous Immune Globulin Therapies Product Offered
11.8.3 China Biologic Products Holdings Intravenous Immune Globulin Therapies Revenue, Gross Margin and Market Share (2017-2019)
11.8.4 Main Business Overview
11.8.5 China Biologic Products Holdings News
11.9 Hualan Biological Engineering
11.9.1 Company Details
11.9.2 Intravenous Immune Globulin Therapies Product Offered
11.9.3 Hualan Biological Engineering Intravenous Immune Globulin Therapies Revenue, Gross Margin and Market Share (2017-2019)
11.9.4 Main Business Overview
11.9.5 Hualan Biological Engineering News
11.10 Sichuan Yuanda Shuyang Pharmaceutical
11.10.1 Company Details
11.10.2 Intravenous Immune Globulin Therapies Product Offered
11.10.3 Sichuan Yuanda Shuyang Pharmaceutical Intravenous Immune Globulin Therapies Revenue, Gross Margin and Market Share (2017-2019)
11.10.4 Main Business Overview
11.10.5 Sichuan Yuanda Shuyang Pharmaceutical News
12 Research Findings and Conclusion
